UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
For
the quarterly period ended
COMMISSION
FILE NO.
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) |
(Address of principal executive office, including Zip Code)
Registrant’s
telephone number, including area code:
Securities registered pursuant to Section 12(b) of the Exchange Act:
| Title of each class | Trading Symbol | Name of Each Exchange on Which Registered | ||
| OTC Markets |
Securities registered pursuant to Section 12(g) of the Exchange Act: None
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. ☐ Yes ☒
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). ☐ Yes ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “accelerated filer”, “large accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ |
| Smaller
reporting company | |
| Emerging
growth company |
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒
As of November 14, 2023, the registrant had shares of Common Stock issued and outstanding.
Nano Magic Inc.
INDEX
| 2 |
FORWARD-LOOKING STATEMENTS
This Form 10-Q contains certain forward-looking statements that we believe are within the meaning of the federal securities laws. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements, including the statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our strategy, future operations, future expectations or future estimates, financial position and objectives of management. Those statements in this Form 10-Q containing the words “believes,” “anticipates,” “plans,” “expects” and similar expressions constitute forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on our current expectations and are subject to a number of risks, uncertainties and assumptions relating to our operations, results of operations, competitive factors, shifts in market demand and other risks and uncertainties.
Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate and actual results may differ from those indicated by the forward-looking statements included in this Form 10-Q. In light of the significant uncertainties inherent in the forward-looking statements included in this Form 10-Q, you should not consider the inclusion of such information as a representation by us or anyone else that we will achieve such results. Moreover, we assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements.
| 3 |
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
NANO MAGIC INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||||
| NET REVENUES | $ | $ | $ | $ | ||||||||||||
| COST OF SALES | ||||||||||||||||
| GROSS PROFIT | ||||||||||||||||
| OTHER OPERATING INCOME | ||||||||||||||||
| OPERATING EXPENSES: | ||||||||||||||||
| Selling and marketing expenses | ||||||||||||||||
| Salaries, wages and related benefits | ||||||||||||||||
| Stock compensation expense | ||||||||||||||||
| Research and development | ||||||||||||||||
| Professional fees | ||||||||||||||||
| General and administrative expenses | ||||||||||||||||
| Total Operating Expense | ||||||||||||||||
| LOSS FROM OPERATIONS | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| OTHER INCOME (EXPENSE) | ||||||||||||||||
| Income (loss) from investment in subsidiary | ( | ) | ||||||||||||||
| Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other income (expense) | ( | ) | ||||||||||||||
| Total Other Income (Expense) | ( | ) | ||||||||||||||
| LOSS FROM CONTINUING OPERATIONS | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| INCOME FROM DISCONTINUED OPERATIONS | ||||||||||||||||
| Income from discontinued operations | ||||||||||||||||
| Gain on sale of discontinued operations | ||||||||||||||||
| NET INCOME FROM DISCONTINUED OPERATIONS | ||||||||||||||||
| NET LOSS | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| NET LOSS PER SHARE - BASIC: | ||||||||||||||||
| Continuing operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Discontinued operations | $ | $ | $ | $ | ||||||||||||
| NET LOSS PER SHARE - BASIC: | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| NET INCOME (LOSS) PER SHARE - DILUTED: | ||||||||||||||||
| Continuing operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Discontinued operations | $ | $ | $ | $ | ||||||||||||
| NET LOSS PER SHARE - DILUTED: | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | ||||||||||||||||
| Basic | ||||||||||||||||
| Diluted | ||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
| F-1 |
NANO MAGIC INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
| September 30 | December 31 | |||||||
| 2023 | 2022 | |||||||
| ASSETS | ||||||||
| CURRENT ASSETS: | ||||||||
| Cash | $ | $ | ||||||
| Accounts receivable, net | ||||||||
| Inventory, net | ||||||||
| Prepaid expenses | ||||||||
| Current portion of note receivable | ||||||||
| Total Current Assets | ||||||||
| Operating lease right-of-use assets | ||||||||
| Property, plant and equipment, net | ||||||||
| Note receivable, non-current | ||||||||
| Non-marketable equity investment in subsidiary | ||||||||
| Total Assets | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| CURRENT LIABILITIES: | ||||||||
| Accounts payable | $ | $ | ||||||
| Accounts payable - related parties | ||||||||
| Accrued expenses and other current liabilities | ||||||||
| Current portion of notes payable | ||||||||
| Current portion of finance leases | ||||||||
| Advances from related parties | ||||||||
| Current portion of operating lease liabilities | ||||||||
| Total Current Liabilities | ||||||||
| Notes Payable, net of current portion | ||||||||
| Finance leases, net of current portion | ||||||||
| Operating lease liabilities, net of current portion | ||||||||
| Total Liabilities | ||||||||
| Commitments and Contingencies (See Note 9) | ||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||
| Preferred stock, $ par value, shares authorized; shares issued and outstanding | ||||||||
| Common stock: $ par value, shares authorized; and issued and outstanding at September 30, 2023 and December 31, 2022, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total Stockholders’ Equity | ||||||||
| Total Liabilities and Stockholders’ Equity | $ | $ | ||||||
See accompanying notes to consolidated financial statements.
| F-2 |
NANO MAGIC INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(unaudited)
| Class A Common Stock | Additional Paid-in | Accumulated | Total Stockholders’ | |||||||||||||||||
| Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||
| Balance, June 30, 2023 | $ | $ | $ | ( | ) | |||||||||||||||
| Common stock issued for cash, net of issuance costs | ||||||||||||||||||||
| Stock-based compensation | - | |||||||||||||||||||
| Restricted stock issued for services | ||||||||||||||||||||
| Warrants and options on private placement | - | ( | ) | ( | ) | |||||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||
| Balance, September 30, 2023 | ( | ) | ||||||||||||||||||
| Balance, June 30, 2022 | $ | $ | $ | ( | ) | |||||||||||||||
| Common stock issued for cash, net of issuance costs | ||||||||||||||||||||
| Stock-based compensation | - | |||||||||||||||||||
| Warrants and options on private placement | - | |||||||||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||
| Balance, September 30, 2022 | ( | ) | ||||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
| F-3 |
NANO MAGIC INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(unaudited)
| Class A Common Stock | Additional Paid-in |
Accumulated | Stockholders’ | |||||||||||||||||
| Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||
| Balance, December 31, 2022 | $ | $ | $ | ( |
) | |||||||||||||||
| Common stock issued for cash, net of issuance costs | ||||||||||||||||||||
| Stock-based compensation | - | |||||||||||||||||||
| Stock issued for services | ||||||||||||||||||||
| Restricted stock issued for services | ||||||||||||||||||||
| Warrants and options on private placement | - | |||||||||||||||||||
| Net loss | - | ( |
) | ( |
) | |||||||||||||||
| Balance, September 30, 2023 | ( |
) | ||||||||||||||||||
| Balance, December 31, 2021 | $ | $ | $ | ( |
) | |||||||||||||||
| Common stock issued for cash, net of issuance costs | ||||||||||||||||||||
| Stock-based compensation | - | |||||||||||||||||||
| Warrants and options on private placement | - | |||||||||||||||||||
| Net loss | - | ( |
) | ( |
) | |||||||||||||||
| Balance, September 30, 2022 | ( |
) | ||||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
| F-4 |
NANO MAGIC INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
| For the Nine Months Ended | ||||||||
| September 30, | ||||||||
| 2023 | 2022 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net loss from continuing operations | $ | ( |
) | $ | ( |
) | ||
| Net income from discontinued operations | ||||||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
| Change in inventory obsolescence reserve | ( |
) | ||||||
| Depreciation and amortization expense | ||||||||
| Bad debt expense | ||||||||
| Stock-based compensation | ||||||||
| Income from investment in subsidiary | ( |
) | ( |
) | ||||
| Change in operating assets and liabilities: | ||||||||
| Accounts receivable | ( |
) | ( |
) | ||||
| Inventory | ||||||||
| Prepaid expenses and contract assets | ||||||||
| Accounts payable | ||||||||
| Accounts payable - related party | ( |
) | ||||||
| Operating lease liabilities | ||||||||
| Accrued expenses | ||||||||
| Contract liabilities | ||||||||
| Total adjustments | ||||||||
| Net cash used by continuing operating activities | ( |
) | ( |
) | ||||
| Net cash used by discontinued operating activities | ( |
) | ||||||
| NET CASH USED BY OPERATING ACTIVITIES | ( |
) | ( |
) | ||||
| CASH FLOWS FROM CONTINUING INVESTING ACTIVITIES | ||||||||
| Proceeds from note receivable | ||||||||
| Purchases of property and equipment | ( |
) | ( |
) | ||||
| NET CASH PROVIDED BY INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM CONTINUING FINANCING ACTIVITIES | ||||||||
| Proceeds from sale of common stock and warrants | ||||||||
| Proceeds from issuance of convertible debt, net of discount | ||||||||
| Repayment of bank loans | ( |
) | ( |
) | ||||
| Repayment of finance leases | ( |
) | ( |
) | ||||
| Repayment of advances from related parties | ( |
) | ||||||
| Net cash provided by continuing financing activities | ||||||||
| Net cash provided by discontinued financing activities | ||||||||
| NET CASH PROVIDED BY FINANCING ACTIVITIES | ||||||||
| NET DECREASE IN CASH | ( |
) | ( |
) | ||||
| CASH in continuing operations, beginning of year | ||||||||
| CASH in discontinued operations, beginning of year | ||||||||
| CASH, end of period | $ | $ | ||||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||||||||
| Cash paid during the period for interest | $ | $ | ||||||
See accompanying notes to condensed consolidated financial statements.
| F-5 |
NANO MAGIC INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(unaudited)
NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION
Organization
Nano Magic Inc. (“we”, “us”, “our”, “Nano Magic” or the “Company”), a Delaware corporation, develops and sells a portfolio of nano-layer coatings, nano-based cleaners, and nano-composite products based on its proprietary technology. On March 2, 2021 we changed our name to Nano Magic Holdings Inc. On December 31, 2022, our wholly-owned subsidiary Nano Magic LLC was merged into the parent company and we changed our name to Nano Magic Inc.
Effective
May 31, 2022, we sold a
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information. Accordingly, they do not include all the information and disclosures required by US GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of September 30, 2023 and for the three and nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023 or any other period. The balance sheet at December 31, 2022 has been derived from the audited financial statement at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures of the Company as of December 31, 2022 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 11, 2023.
Going Concern
These
unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets
and the settlement of liabilities and commitments in the normal course of business. As reflected in the unaudited consolidated financial
statements, the Company had losses from continuing operations and net cash used by continuing operations of $
Reclassifications
Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period. These reclassifications had no effect on the previously reported net loss.
| F-6 |
NOTE 2 – DISCONTINUED OPERATIONS
Effective
May 31, 2022, we sold a
In connection with the sale, the capital structure of Applied Nanotech was changed to give us, as the holder of Class B common stock of Applied Nanotech, a 30% economic interest, certain information rights, special consent rights, and tag-along rights, as well as the obligation to sell our stock under certain circumstances if other stockholders are selling. The Class A stock acquired by the buyers was pledged to secure the promissory note given in payment of the purchase price.
The following includes the detail of major classes of assets and liabilities of discontinued operations summarized on the accompanying unaudited consolidated financial statements:
The following is the detail of major line items that constitute income (loss) from discontinued operations:
| For the Nine Months Ended | ||||||||
| September 30, | ||||||||
| 2023 | 2022 | |||||||
| Net Revenues | $ | $ | ||||||
| Cost of Sales | ||||||||
| Gross Profit | ||||||||
| Salaries, wages and related benefits | ||||||||
| General and administrative expenses | ||||||||
| Professional fees | ||||||||
| Interest and other expense | ||||||||
| Net income (loss) on discontinued operations | $ | $ | ||||||
NOTE 3 – ACCOUNTS RECEIVABLE
At September 30, 2023 and December 31, 2022, accounts receivable consisted of the following:
| September 30, 2023 | December 31, 2022 | |||||||
| Accounts receivable | $ | $ | ||||||
| Less: allowance for doubtful accounts | ( | ) | ( | ) | ||||
| Accounts receivable, net | $ | $ | ||||||
NOTE 4 – INVENTORY
At September 30, 2023 and December 31, 2022, inventory consisted of the following:
| September 30, 2023 | December 31, 2022 | |||||||
| Raw materials | $ | $ | ||||||
| Work-in-progress | ||||||||
| Finished goods | ||||||||
| Less: reserve for obsolescence | ( | ) | ( | ) | ||||
| Inventory, net | $ | $ | ||||||
NOTE 5 – INVESTMENT IN SUBSIDIARY
The
Company is accounting for its
| F-7 |
NOTE 6 – NOTES PAYABLE AND FINANCE LEASES
Notes Payable
On
January 7, 2022, the Company sold to one investor a $
On
July 27, 2022, the Company sold two convertible notes, one for $
On
October 26, 2022, the Company sold to an investor a $
On
December 18, 2022, the Company issued a convertible promissory note for $
On
June 14, 2023, the Company issued a convertible, secured note and warrants to purchase
On July 24, 2023, the Company issued at face value a convertible note in
the original principal amount of $
At
September 30, 2023 and at December 31, 2022, we had outstanding convertible notes aggregating $
On
February 10, 2015, Nano Magic entered into a $
Finance Leases
On
August 11, 2020, the company entered into a finance lease for furniture. The Company financed $
On
September 24, 2020, the company entered into a finance lease with Raymond Leasing Corporation for a forklift. Nano Magic LLC financed
$
In
December 2020, the company entered into a finance lease for production equipment. The Company financed $
| F-8 |
NOTE 7 – RELATED PARTY TRANSACTIONS
At
September 30, 2023 and at December 31, 2022, accounts payable – related parties totaled $
Other compensation paid to directors was:
| Three Months ended September 30, | Nine Months ended September 30, | |||||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||||
| Ronald J. Berman | $ | $ | + | $ | $ | + | ||||||||||
| Tom J. Berman | $ | * | $ | * | $ | * | $ | * | ||||||||
| + | |
| * |
At
September 30, 2023 and at December 31, 2022, aggregate advances from Scott & Jeanne Rickert were $
We granted options to our President and CEO Tom Berman in lieu of salary: In April, an option to purchase up to shares, fully vested for salary not paid from January to March, and, in May, a second option for up to shares that vest at the rate of shares monthly for salary not paid in April and subsequent months of 2023. Also in May, we granted our Chief Financial Officer an option for up to shares in recognition of his services from 2019 through 2022. Both our CFO and our General Counsel were granted options in May for up to shares, vesting shares per month starting in January 2023 and each month thereafter. In May, 2023, we also granted director Ronald Berman an option to purchase up to shares for services previously rendered and granted him an option for shares that vest at the rate of shares per month beginning in April and for each calendar month of 2023. All options have an exercise price of $ per share and a four-year term.
One
of the purchasers of the
Mr. Ron Berman and Mr. Tom Berman are the managers of the limited liability company that is the manager of PEN Comeback, LLC, PEN Comeback 2, LLC, Magic Growth, LLP, Magic Growth 2 LLC and Magic Growth 3 LLC. These five limited liability companies purchased shares of common stock and derivative securities from us in 2018, 2019, 2020, 2021 and 2022. See the subsection on Sales of Stock under Issuances of Common Stock in Note 8.
In
addition, Mr. Tom Berman and Mr. Ron Berman are two of three individuals who share voting power of the sole manager of the limited liability
company that is the Company’s landlord in Michigan. Together, Tom and Ron Berman hold, in the aggregate, a
NOTE 8 – STOCKHOLDERS’ EQUITY
Description of Preferred and Common Stock
Preferred Stock
The preferred stock may be issued in one or more series. The Company’s board of directors are authorized to issue the shares of preferred stock in such series and to fix from time to time before issuance thereof the number of shares to be included in any such series and the designation, powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, of such series.
Common Stock
| F-9 |
Issuances of Common Stock
Common Stock Issued for Services
In February 2023, we reached an agreement with the landlord of our Michigan facility to accept shares of our common stock at a price of $ per share as partial payment of rent for the nine-month period from October 2022 through March 2023. Those shares were issued in March, 2023.
In May 2023, we reached a further agreement with the landlord that calls for us to pay cash each month to cover the cost of the mortgage and the lease for the lighting fixtures, but that will allow us to pay the balance of the rent by issuing shares of our stock valued at $ per share. We have the option to continue to use stock to pay a portion of the rent through 2024.
On May 30, 2023, the Company issued shares of restricted common stock to a consultant as compensation for services. The shares are subject to forfeiture until vested. So long as the consulting services agreement remains in effect shares vested in May for prior service, and another shares vest at the end of May and each calendar month thereafter, with shares vesting in December 2023. During 2024, shares will vest at the end of each month, with shares vesting at the end of December 2024.
In August the Company issued to each of three individuals who are serving on its advisory committee a total of shares of restricted stock for their services during 2023. All shares vest ratably by December 31, 2023.
Sales of Common Stock and Derivative Equity Securities
During
the quarter ended September 30, 2023, the Company sold an additional
shares of common stock for proceeds of $
During
the quarter ended September 30, 2022, the Company sold shares of common stock for proceeds of $
Stock Options
Stock options to purchase common stock outstanding at September 30, 2023 include those described below. No options were exercised during the period. No options have been included in diluted earnings per share as they would be anti-dilutive.
| Number of Options | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term (Years) | Aggregate Intrinsic Value | |||||||||||||
| Outstanding December 31, 2022 | $ | $ | ||||||||||||||
| Exercised | - | |||||||||||||||
| Issued | ||||||||||||||||
| Expired & forfeited | ) | - | ) | |||||||||||||
| Outstanding September 30, 2023 | $ | $ | ||||||||||||||
| Exercisable September 30, 2023 | $ | $ | ||||||||||||||
September 30, 2023 | December 31, 2022 | |||||||
| Stock options | | |||||||
| Stock warrants | ||||||||
| Total | ||||||||
| F-10 |
Warrants
During the three-month period ended September 30, 2023, no warrants were
issued, but, in connection with the additional shares issued to the investor who bought shares and warrants in April 2023, the investor
and the Company agreed to cancel the warrants to purchase shares that had been issued to that investor in April. As
of September 30, 2023, there were outstanding and exercisable warrants to purchase
2021 Equity Incentive Plan
On March 2, 2021, our Board adopted the 2021 Nano Magic 2021 Equity Incentive Plan (the “Plan”) to allow equity compensation for those who provide services to the Company and to encourage ownership in the Company by personnel whose service to the Company is important to its continued progress, to encourage recipients to act as owners and thereby in the stockholders’ interest and to enable recipients to share in the Company’s success. Initially, shares were available for issuance under the Plan and that number of options were also granted to employees on March 2, 2021. On April 8, 2021 the number of shares under the Plan was increased by , and an additional options were granted. On June 21, 2021 an additional shares were made available for issuance under the Plan and options for shares were granted, but subsequently forfeited. In February 2022, we granted options with an exercise price of $ and weighted average fair value on the grant date of $.
On April 12, 2023, the Company granted options under the 2021 Equity Plan. On May 30, 2023 the Board granted an additional options under the 2021 Equity Plan to employees and a consultant. All options are at an exercise price of $.
Other Options
On April 12, 2023, the Company issued an additional options to Tom J. Berman, our President. On May 30, 2023, the Board granted options to officers and to a consultant who is also a director.
NOTE 9 – COMMITMENTS AND CONTINGENCIES
Litigation
The Company may be, from time to time, subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. As of September 30, 2023 we were not a defendant in any proceedings. Our policy is to accrue costs for contingent liabilities, including legal proceedings or unasserted claims that may result in legal proceedings, when a liability is probable and the amount can be reasonably estimated. As of September 30, 2023, the Company has not accrued any amount for litigation contingencies.
NOTE 10 – SUBSEQUENT EVENTS
On October 16, 2023, the Company issued shares of common stock to its landlord in Michigan in partial payment of rent.
On October 18, 2024, the Company and the holder of
a convertible note dated October 26, 2022 in the original principal amount of $
On October 16, and again on October 26,
2023, the Company sold shares
of common stock to an accredited investor for proceeds of $
On November 7, 2023, the Company sold shares
of common stock to an accredited investor for proceeds of $
On November 9, 2023, the Company sold shares
of common stock to an accredited investor for proceeds of $
| F-11 |
ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying unaudited condensed consolidated financial statements.
OVERVIEW
Nano Magic is a leader in developing and bringing to market cutting-edge nanotechnology-powered industrial and consumer cleaning, protection and anti-fog solutions formulated in Detroit, Michigan. Nano Magic focuses on innovative and advanced product solutions harnessing the magic power of nanotechnology to create a safer, more socially conscious, and higher performing world. Visit www.nanomagic.com for more information.
Effective May 31, 2022, we sold a majority interest in our subsidiary, Applied Nanotech, Inc. (“ANI”). ANI performs contract research services for the Company and for governmental and private customers and that work was previously reported as our Contract research segment. We retain a 30% interest in ANI that is now recorded as an equity investment.
RESULTS OF OPERATIONS
The following comparative analysis on results of operations was based primarily on the comparative condensed consolidated financial statements, footnotes and related information for the periods identified below and should be read in conjunction with the unaudited condensed consolidated financial statements and the notes to those statements that are included elsewhere in this report. The results discussed below are for the three and nine months ended September 30, 2023 and 2022.
Comparison of Results of Continuing Operations for the Three and Nine Months ended September 30, 2023 and 2022
Revenues:
For the three and nine months ended September 30, 2023 and 2022, revenues from continuing operations were:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||||
| Total revenue | $ | 658,159 | $ | 807,026 | $ | 2,064,481 | $ | 1,819,951 | ||||||||
For the three months ended September 30, 2023, revenues from continuing operations decreased by $148,867 or 18% as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023 revenues increased by $244,530 or 13%, as compared to the nine months ended September 30, 2022. The decrease experienced in 2023 was due to large e-commerce sales for the three-month period in 2022, and the increase for the nine-month period was due, primarily, to new retail programs.
Cost of sales
Cost of sales includes inventory costs, materials and supplies costs, internal labor and related benefits, subcontractor costs, depreciation, and allocated overheads and shipping and handling costs incurred.
| Three Months ended September 30, | Nine Months ended September 30, | |||||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||||
| Cost of sales: | $ | 575,680 | $ | 698,448 | $ | 1,705,114 | $ | 1,689,342 | ||||||||
For the three months ended September 30, 2023, cost of revenues decreased by $122,768 or 18% as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, cost of revenues increased by $15,772 or 1% as compared to the nine months ended September 30, 2022. Cost of sales changed as a result of a favorable product mix change, and increased efficiency and cost cutting efforts over the last year, offset by an increase in the reserve for slow-moving inventory.
| 4 |
Gross profit
For the three months ended September 30, 2023, gross profit was $82,479 as compared to $108,578 for the prior year, a decrease of $26,099 or 24%. For the nine months ended September 30, 2023, gross profit was $359,367 as compared to $130,609 for the same period in the prior year, an increase of $228,758 or 175%. For the three-month period, the decrease was largely due to an increase in the reserve for slow-moving inventory. In the nine-month period, the increase was due to an emphasis on higher margin sales.
Other Operating Income
For the three and nine months ended September 30, 2023, other operating income amounted to $0 and $11,420 as compared to $95,701 for the three and nine months ended September 30, 2022. The difference is due to the recognition of one-time income booked for the settlement of claims.
Operating expenses
For the three months ended September 30, 2023, operating expenses decreased by $19,937 or 3% compared to the three months ended September 30, 2022. For the nine-month period ended September 20, 2023, operating expenses decreased by $297,433 or 11% as compared to the nine months ended September 30, 2022. For the three and nine months ended September 30, 2023 and 2022, operating expenses consisted of the following:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||||
| Selling and marketing expenses | $ | 69,242 | $ | 88,635 | $ | 182,684 | $ | 264,465 | ||||||||
| Salaries, wages and related benefits | 233,701 | 308,745 | 702,263 | 1,021,463 | ||||||||||||
| Stock compensation expense | 119,999 | 50,528 | 410,392 | 157,149 | ||||||||||||
| Research and development | 24,375 | 4,566 | 36,650 | 15,266 | ||||||||||||
| Professional fees | 78,080 | 129,362 | 380,301 | 572,135 | ||||||||||||
| General and administrative expenses | 220,230 | 183,728 | 667,744 | 646,989 | ||||||||||||
| Total | $ | 745,627 | $ | 765,564 | $ | 2,380,034 | $ | 2,677,467 | ||||||||
| ● | For the three months ended September 30, 2023, selling and marketing expenses decreased by $19,393 or 22% as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, selling and marketing expenses decreased by $81,781 or 31% as compared to the nine months ended September 30, 2022. The decreases were due to reductions in marketing and advertising, attendance at fewer trade shows in 2023 and reduced costs for shows attended. |
| ● | For the three months ended September 30, 2023, salaries, wages and related benefits decreased by $75,044 or 24%, as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, salaries, wages and related benefits decreased by $319,200 or 31%, as compared to the nine-months ended September 30, 2022. These decreases were due to reductions in headcount. |
| ● | For the three months ended September 30, 2023, stock compensation expense increased by $69,471 or 137%. For the nine months ended September 30, 2023, stock compensation expense increased $253,243 or 161%. The increase was due in substantial part to the grant of options to employees in lieu of cash bonuses, payment of a portion of some salaries in options in lieu of cash, and other stock incentives to employees, consultants and advisors. |
| ● | For the three months ended September 30, 2023, research and development costs increased by $19,809 or 434%, as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, research and development costs increased by $21,384 or 140%, as compared to the nine months ended September 30, 2022. The increase for the three-month period was due primarily to consulting costs and that was the largest component of the change for the nine-month period. |
| ● | For the three months ended September 30, 2023, professional fees decreased by $51,282 or 40%, as compared to the three months ended September 30, 2022. For the nine months ended September 30, 2023, professional fees decreased by $191,834 or 34%, as compared to the nine months ended September 30, 2022. The changes were due to a reduction in fees from professional services firms used by the Company, particularly reduced legal fees. |
| ● | For the three months ended September 30, 2023, general and administrative expenses increased by $36,502 or 20% as compared to the three months ended September 30, 2022 due to an increase in bad debt expenses for the quarter. For the nine months ended September 30, 2023, general and administrative expenses increased by $20,755 or 3% as compared to the nine months ended September 30, 2022. The difference for the three-month period was due to timing, but the costs are essentially flat year to date. |
| 5 |
Loss from operations
As a result of the factors described above, for the three months ended September 30, 2023, loss from operations amounted to $663,148 as compared to a loss of $561,285 for the three months ended September 30, 2022, an increase of $101,863 or 18%. For the nine months ended September 30, 2023, loss from operations amounted to $2,009,247 as compared to a loss of $2,451,157 for the nine months ended September 30, 2022, a reduction of $441,910 or 18%.
Income from investment in subsidiary
As a result of the sale of a 70% interest in ANI , we now report our 30% share of ANI’s income or loss as an investment in a subsidiary. For the three and nine months ended September 30, 2023 there was a loss of $21,267, and income of $19,671, respectively. For the three and nine-month periods ended September 30, 2022, we recorded income from that investment of $19,203 and $16,042, respectively.
Interest expense
For the three months ended September 30, 2023 interest expense was $12,068 as compared to $10,799 in the prior year, and for the nine months ended September 30, 2023 interest expense was $34,011 up from $26,414 in the prior year. The increases for the three- and nine-month comparative periods was due to accrued interest on convertible notes outstanding.
Other income (expense)
For the three months ended September 30, 2023, other expense was $3,192 as compared to income of $10,267 for the three months ended September 30, 2022. For the nine months ended September 30, 2023, other income was $20,010 as compared to $12,892 for the nine months ended September 30, 2022. The difference in the three-month period was due to a one-time tax expense and for the nine-month period due to increased interest accrued on the note receivable from ANI.
Loss from continuing operations
As a result of the foregoing, we reported a loss from continuing operations of $699,675 for the three-month period ended September 30, 2023 and a loss of $542,594 for the three-month period in the prior year, an increase of $157,081 or 29%. For the nine-month period ended September 30, 2023 our loss from continuing operations was $2,003,577 as compared to $2,448,637 for the nine-month period ended September 30, 2022, a reduction of $445,060 or 18%.
Income (loss) from discontinued operations
Effective May 31, 2022, we sold a 70% interest in our subsidiary ANI to two of its officers and long-time employees in exchange for a promissory note in the face amount of $450,000. On a continuing basis, we no longer recognize income from this operation in the statement of operations. For the nine months ended September 30, 2022, we recognized income of $1,300 and a one-time gain on the sale of discontinued operations of $1,148,225.
Net loss (income)
For the three months ended September 30, 2023, net loss was $699,675 as compared to a loss of $542,594 for the three months ended September 30, 2022. For the nine months ended September 30, 2023, net loss amounted to $2,003,577 as compared to a loss of $1,299,112 for the nine months ended September 30, 2022.
LIQUIDITY AND CAPITAL RESOURCES
Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had working capital of $31,507 and $123,173 of unrestricted cash as of September 30, 2023 and working capital of $524,389 and $259,223 of unrestricted cash as of December 31, 2022.
The following table sets forth a summary of changes in our working capital from December 31, 2022 to September 30, 2023:
December 31, 2022 to September 30, 2023 | ||||||||||||||||
| September 30, 2023 | December 31, 2022 | Change in Working Capital | Percentage Change | |||||||||||||
| Working capital: | ||||||||||||||||
| Total current assets | $ | 1,572,117 | $ | 1,900,858 | $ | (328,741 | ) | (17.29 | )% | |||||||
| Total current liabilities | 1,540,610 | 1,376,469 | 164,141 | 11.92 | % | |||||||||||
| Working capital: | $ | 31,507 | $ | 524,389 | $ | (492,882 | ) | (93.99 | )% | |||||||
The decrease in current assets was primarily due to a reduction in cash and in inventory. The increase in current liabilities was primarily due to an increase in accrued expenses.
| 6 |
Net cash used by operating activities was $(1,057,794) for the nine months ended September 30, 2023 as compared to net cash used by operating activities of $(1,561,063) for the nine months ended September 30, 2022, a net change of $503,269 or a reduction of 32%. Net cash used by operating activities for the nine months ended September 30, 2023 primarily resulted from net loss from continuing operations of $2,003,577 adjusted for add-backs of $697,590 and changes in operating assets and liabilities of $248,193.
Net cash provided by continuing investing activities was $10,648 for the nine months ended September 30, 2023, as compared to $20,090 for the same period in 2022. The change was due in substantial part to purchases of equipment and tooling as well as a reduction in proceeds from a note receivable.
Net cash provided by continuing financing activities was $911,096 for the nine months ended September 30, 2023 reflecting $950,332 in proceeds from sales of common stock, warrants and convertible notes, as compared to net cash provided by continuing financing activities of $1,484,785 for the same period in 2022. Net cash provided by discontinued financing activities was $0 and $20,000 for the nine months ended September 30, 2023 and September 30, 2022, respectively.
Future Liquidity and Capital Needs.
Our principal future uses of cash are for working capital requirements, including working capital to support increased product sales, sales and marketing expenses and reduction of accrued liabilities. Application of funds among these uses will depend on numerous factors including our sales and other revenues and our ability to control costs.
Equipment Financing and Loans
See note 6 to our unaudited condensed consolidated financial statements regarding our equipment loan and financing leases.
Off-Balance Sheet Arrangements
We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as shareholder’s equity or that are not reflected in our consolidated unaudited financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.
ITEM 3. Quantitative and Qualitative disclosures about market risk
Not applicable to smaller reporting companies.
ITEM 4. Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report (the “Evaluation Date”). Based upon this evaluation, our principal executive officer and principal financial officer concluded that we do not have sufficient resources in our accounting function to have segregation of duties so that the initiation of transactions, the custody of assets and the recording of transactions are performed by separate individuals. However, to the extent possible, these tasks are performed by separate individuals. Management evaluated our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.
Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.
Changes in Internal Control
There were no changes identified in connection with our internal control over financial reporting during the three months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
| 7 |
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None
ITEM 1A. RISK FACTORS
Not required of smaller reporting companies.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On April 12, 2023, the Company granted 47,610 options under the 2021 Equity Plan and an additional 30,000 in options to Tom J. Berman our President. The options were granted to individuals in lieu of cash for a portion of their salary for the period from December 31, 2022 through March 31, 2023. All options are at an exercise price of $0.65 per share for a four-year term and were fully vested on date of grant.
On April 14, 2023, the Company sold 196,851 shares of common stock to an accredited investor for proceeds of $246,064 and sold to that investor warrants to purchase up to 196,813 shares of common stock for proceeds of $3,936. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75.
On May 8, 2023, as part of a settlement agreement entered into on April 27, 2023, the Company sold to the counterparty 57,143 shares of common stock for proceeds of $100,000 at a price of $1.75 per share.
In March 2023, we issued 52,800 shares of common stock to our landlord in partial payment of our rent in Michigan.
On May 30, 2023 the Board granted 175,071 options under the 2021 Equity Plan to employees and consultants and an additional 399,228 options to officers and to a consultant who is also a director. All options are at an exercise price of $0.65 per share.
On May 30, 2023, the Company issued 76,922 shares of restricted common stock to a consultant as compensation for services.
On June 16, 2023, the Company issued a note at face value of $50,000 and sold that investor, for a price of $0.02 per warrant, warrants to purchase up to 10,000 shares of common stock at an exercise price of $1.75. On July 24, 2023, the Company sold a convertible note at its face amount of $50,000. On that same day, the Company sold 133,333 shares of common stock for proceeds of $100,000.
On July 24, 2023, the Company issued at face value a convertible note in the original principal amount of $50,000. The note is due two years from date of issue, bears interest at 8% per annum and is convertible at $1.25 per share.
On July 25, 2023, the Company issued 133,333 shares to an accredited investor at a price of $0.75 for proceeds of $100,000. In July and August 2023, the Company granted an aggregate of 192,302 shares of restricted stock to four individuals who will serve on the advisory committee. In August 2023, the Company issued 366,665 additional shares to accredited investors at a price of $0.75 per share for proceeds of $275,000. In September the Company issued 33,333 shares to another investor at that price for proceeds of $25,000. In addition, an investment made in April was cancelled and the $250,000 investment was reissued at $0.75 per share, resulting in a net increase in the outstanding stock of 136,482 shares.
On October 16, 2023, the Company issued 52,800 shares of common stock to its landlord in Michigan in partial payment of rent. On October 16, and again on October 26, 2023, the Company sold 13,333 shares of common stock to an accredited investor for proceeds of $10,000 on each of those two dates.
On November 7, 2023, the Company sold 39,999 shares of common stock to an accredited investor for proceeds of $30,000.
On November 9, 2023, the Company sold 266,667 shares of common stock to an accredited investor for proceeds of $200,000.
Grants under the 2021 Equity Plan were exempt under Rule 701. The sales and issuances of stock and other securities were exempt from registration under Section 4(a)(2) of the Securities Act. Cash proceeds were used for general corporate purposes.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
| 8 |
ITEM 6. EXHIBITS
| Exhibit
No. |
Description | |
| 31.1* | Rule 13a-14(a)/15d-14(a) Certificate of Principal Executive Officer | |
| 31.2* | Rule 13a-14(a)/15d-14(a) Certificate of Chief Financial Officer | |
| 32.1* | Section 1350 Certificate of Principal Executive Officer and Chief Financial Officer | |
| 101.INS | Inline XBRL Instance Document | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition | |
| 101.LAB | Inline XBRL Taxonomy Extension Labels | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
| * | Filed herewith. |
| 9 |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
Nano Magic Inc. | |
| (Registrant) | |
| Date: November __, 2023 | /s/ Tom J. Berman |
| Tom J. Berman, | |
| President and Chief Executive Officer | |
| Date: November __, 2023 | /s/ Leandro Vera |
| Leandro Vera | |
| Chief Financial Officer |
| 10 |